Loss of Protooncogene c-Myc Function Impedes G1 Phase Progression Both before and after the Restriction Point

AUTOR(ES)

Schorl, Christoph

FONTE

The American Society for Cell Biology

RESUMO

c-myc is an important protooncogene whose misregulation is believed to causally affect the development of numerous human cancers. c-myc null rat fibroblasts are viable but display a severe (two- to threefold) retardation of proliferation. The rates of RNA and protein synthesis are reduced by approximately the same factor, whereas cell size remains unaffected. We have performed a detailed kinetic cell cycle analysis of c-myc−/− cells by using several labeling and synchronization methods. The majority of cells (>90%) in asynchronous, exponential phase c-myc−/− cultures cycle continuously with uniformly elongated cell cycles. Cell cycle elongation is due to a major lengthening of G1 phase (four- to fivefold) and a more limited lengthening of G2 phase (twofold), whereas S phase duration is largely unaffected. Progression from mitosis to the G1 restriction point and the subsequent progression from the restriction point into S phase are both drastically delayed. These results are best explained by a model in which c-Myc directly affects cell growth (accumulation of mass) and cell proliferation (the cell cycle machinery) by independent pathways.

Documentos Relacionados

• c-myc antisense transcripts accelerate differentiation and inhibit G1 progression in murine erythroleukemia cells.
• Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma
• Loss of FBP function arrests cellular proliferation and extinguishes c-myc expression
• Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas.
• Effects of c-myc expression on cell cycle progression.